The post Nvidia enrollment sends this stock soaring 130% appeared on BitcoinEthereumNews.com. Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program. By press time, the stock was trading at $3.06, up 127%, though it remains down more than 20% year-to-date. PRFX one-day stock price chart. Source: Google Finance Through the Nvidia program, DeepSolar will gain access to advanced AI frameworks, development tools, and engineering support to further develop DeepSolar Predict, its solar forecasting solution for photovoltaic systems. The platform is designed to boost weather forecast accuracy by up to 50%, helping solar asset owners reduce imbalance penalties, optimize energy sales, and improve grid stability. “By combining NVIDIA’s AI capabilities with DeepSolar’s domain expertise, we believe that DeepSolar Predict has the potential to redefine how photovoltaic energy is forecasted and optimized,” said Ehud Geller, Chairman and Interim CEO of PainReform. PainReform said the current version of its platform has already demonstrated the ability to increase energy production and cut operating and maintenance costs by as much as 30%. PainReform struggles  Despite Tuesday’s surge, PainReform shares have lost more than 80% over the past year. The company, which combines pharmaceutical development for post-surgical pain relief with AI-driven renewable energy optimization, has struggled in recent months. The Nvidia partnership comes alongside an expansion into biotechnology through a majority stake acquisition in Boston-based LayerBio. Notably, the deal supports the development of OcuRing-K, a drug delivery system for managing pain and inflammation after cataract surgery. The investment could reach $3 million, with $600,000 already committed and the rest contingent on development milestones. Featured image via Shutterstock Source: https://finbold.com/nvidia-enrollment-sends-this-stock-soaring-130/The post Nvidia enrollment sends this stock soaring 130% appeared on BitcoinEthereumNews.com. Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program. By press time, the stock was trading at $3.06, up 127%, though it remains down more than 20% year-to-date. PRFX one-day stock price chart. Source: Google Finance Through the Nvidia program, DeepSolar will gain access to advanced AI frameworks, development tools, and engineering support to further develop DeepSolar Predict, its solar forecasting solution for photovoltaic systems. The platform is designed to boost weather forecast accuracy by up to 50%, helping solar asset owners reduce imbalance penalties, optimize energy sales, and improve grid stability. “By combining NVIDIA’s AI capabilities with DeepSolar’s domain expertise, we believe that DeepSolar Predict has the potential to redefine how photovoltaic energy is forecasted and optimized,” said Ehud Geller, Chairman and Interim CEO of PainReform. PainReform said the current version of its platform has already demonstrated the ability to increase energy production and cut operating and maintenance costs by as much as 30%. PainReform struggles  Despite Tuesday’s surge, PainReform shares have lost more than 80% over the past year. The company, which combines pharmaceutical development for post-surgical pain relief with AI-driven renewable energy optimization, has struggled in recent months. The Nvidia partnership comes alongside an expansion into biotechnology through a majority stake acquisition in Boston-based LayerBio. Notably, the deal supports the development of OcuRing-K, a drug delivery system for managing pain and inflammation after cataract surgery. The investment could reach $3 million, with $600,000 already committed and the rest contingent on development milestones. Featured image via Shutterstock Source: https://finbold.com/nvidia-enrollment-sends-this-stock-soaring-130/

Nvidia enrollment sends this stock soaring 130%

2025/08/19 22:19
2분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 [email protected]으로 연락주시기 바랍니다

Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program.

By press time, the stock was trading at $3.06, up 127%, though it remains down more than 20% year-to-date.

PRFX one-day stock price chart. Source: Google Finance

Through the Nvidia program, DeepSolar will gain access to advanced AI frameworks, development tools, and engineering support to further develop DeepSolar Predict, its solar forecasting solution for photovoltaic systems.

The platform is designed to boost weather forecast accuracy by up to 50%, helping solar asset owners reduce imbalance penalties, optimize energy sales, and improve grid stability.

PainReform said the current version of its platform has already demonstrated the ability to increase energy production and cut operating and maintenance costs by as much as 30%.

PainReform struggles 

Despite Tuesday’s surge, PainReform shares have lost more than 80% over the past year. The company, which combines pharmaceutical development for post-surgical pain relief with AI-driven renewable energy optimization, has struggled in recent months.

The Nvidia partnership comes alongside an expansion into biotechnology through a majority stake acquisition in Boston-based LayerBio.

Notably, the deal supports the development of OcuRing-K, a drug delivery system for managing pain and inflammation after cataract surgery. The investment could reach $3 million, with $600,000 already committed and the rest contingent on development milestones.

Featured image via Shutterstock

Source: https://finbold.com/nvidia-enrollment-sends-this-stock-soaring-130/

시장 기회
Moonveil 로고
Moonveil 가격(MORE)
$0.00005547
$0.00005547$0.00005547
-1.73%
USD
Moonveil (MORE) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!